|
|
|
|
|
SomaLife gHP Research
HGH & Dietary Supplements
SomaLife gHP, a product for the new millennium, was conceived, developed and tested by a world-renowned team of physicians and biochemists who are in the emerging field of longevity medicine. Classified as a nutritional dietary supplement, SomaLife gHP is a critical combination of amino acids, which, when taken orally, has the potential to stimulate the pituitary gland to secrete growth hormone.
Human growth hormone is recognized not only to be important in promoting growth in children, but also in maintaining cellular integrity thereafter.
The rationale behind the development of SomaLife gHP was the well documented association between aging and the decline in the release of growth hormone, which occurs after growth is completed around age eighteen. Recognition of this association led to the use of growth hormone injections during the 1990s by the 'rich and famous' who could afford this expensive exercise, and thereby enjoy the evident anti-aging effects.
SomaLife gHP, on the other hand, offers the same longevity effects, but with a relatively inexpensive oral product which is being enthusiastically received by a rapidly expanding group of several thousand users. Evidence of SomaLife gHP's acceptance would appear to be validated by the continued use of the product (at an affordable cost), accompanied by positive testimonials on its effectiveness. Because the amino acids in SomaLife gHP are some of those normally used by the body in cellular metabolism and protein production, the potential elevation of growth hormone levels cannot exceed normal levels for an individual. So consequently, significant negative effects have not been observed or reported, and are not expected.
SomaLife gHP is manufactured from the highest quality, imported amino acids under carefully controlled conditions. Each batch of the product is subjected to high quality control testing before it is released to the central distribution centre. SomaLife's sophisticated computerized system, together with its well trained and motivated staff, ensures timely fulfillment of product delivery following registration of a user with SomaLife Health Products Inc.
Moe S. Aziz BSc (Biochemistry), MBA
President & CEO of Sino Pharmaceuticals
Be sure to read Turning Back The Clock
SomaVit Research
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.
Age-Related Eye Disease Study Research Group.
Background: Observational and experimental data suggest that antioxidant and/or zinc supplements may delay progression of age-related macular degeneration (AMD) and vision loss.
Objective: To evaluate the effect of high-dose vitamins C and E, beta carotene, and zinc supplements on AMD progression and visual acuity.
Design: The Age-Related Eye Disease Study, an 11-center double-masked clinical trial, enrolled participants in an AMD trial if they had extensive small drusen, intermediate drusen, large drusen, noncentral geographic atrophy, or pigment abnormalities in 1 or both eyes, or advanced AMD or vision loss due to AMD in 1 eye. At least 1 eye had best-corrected visual acuity of 20/32 or better. Participants were randomly assigned to receive daily oral tablets containing:
- antioxidants (vitamin C, 500 mg; vitamin E, 400 IU; and beta carotene, 15 mg);
- zinc, 80 mg, as zinc oxide and copper, 2 mg, as cupric oxide;
- antioxidants plus zinc; or
- placebo.
Main Outcome Measures: (1) Photographic assessment of progression to or treatment for advanced AMD and (2) at least moderate visual acuity loss from baseline (> or =15 letters). Primary analyses used repeated-measures logistic regression with a significance level of.01, unadjusted for covariates. Serum level measurements, medical histories, and mortality rates were used for safety monitoring.
Results: Average follow-up of the 3640 enrolled study participants, aged 55-80 years, was 6.3 years, with 2.4% lost to follow-up. Comparison with placebo demonstrated a statistically significant odds reduction for the development of advanced AMD with antioxidants plus zinc (odds ratio [OR], 0.72; 99% confidence interval [CI], 0.52-0.98). The ORs for zinc alone and antioxidants alone are 0.75 (99% CI, 0.55-1.03) and 0.80 (99% CI, 0.59-1.09), respectively. Participants with extensive small drusen, nonextensive intermediate size drusen, or pigment abnormalities had only a 1.3% 5-year probability of progression to advanced AMD. Odds reduction estimates increased when these 1063 participants were excluded (antioxidants plus zinc: OR, 0.66; 99% CI, 0.47-0.91; zinc: OR, 0.71; 99% CI, 0.52-0.99; antioxidants: OR, 0.76; 99% CI, 0.55-1.05). Both zinc and antioxidants plus zinc significantly reduced the odds of developing advanced AMD in this higher-risk group. The only statistically significant reduction in rates of at least moderate visual acuity loss occurred in persons assigned to receive antioxidants plus zinc (OR, 0.73; 99% CI, 0.54-0.99). No statistically significant serious adverse effect was associated with any of the formulations.
Conclusions: Persons older than 55 years should have dilated eye examinations to determine their risk of developing advanced AMD. Those with extensive intermediate size drusen, at least 1 large druse, noncentral geographic atrophy in 1 or both eyes, or advanced AMD or vision loss due to AMD in 1 eye, and without contraindications such as smoking, should consider taking a supplement of antioxidants plus zinc such as that used in this study.
Publication Types:
- Clinical Trial
- Multicenter Study
- Randomized Controlled Trial
SomaLife Memory Research
Mental Decline - inevitable part of aging?
Memories are recollections that establish who we are and to some extent define our future path. As we age, most of us are subject to forgetfulness. Usually we make allowances for this decline but as time passes it becomes more noticeable and frequently embarrassing.
It has long been thought that those who stay active and mentally alert can significantly delay the natural age-related decline in memory. It is now recognized that the gradual loss of nerve cells and connections within the brain begins at age six, the age at which they are at their maximum. This suggests that the aging process in relation to memory commences at that age. When we get to our sixties the cumulative affect can become noticeable, in the form of age related memory loss. Any loss of memory, no matter how mild, can be profoundly disturbing!
It is now recognized that there is a slow loss over time of nerve cells and connections in the brain commencing at age six, the age at which they are their maximum. This would suggest that the aging process in relation to memory commences at that age. When we get to our sixties the situation begins to looks rather bleak.
It is impossible to exaggerate the importance of memory to ancient cultures where all learning was passed down the generations by word of mouth without the benefit of written language. For more than 3000 years the ancients of India have been using a specific plant extract that was recognized for its beneficial influence upon memory. * The SomaLife Scientific Team are justifiable proud to now have acquired the rights to that specific plant extract which, by utilizing the most current available clinical research has now been enhanced and developed as SomaLife Memory..
The SomaLife Memory formulation contains a unique standardized extract of Bacopa Monniera, commonly known as Brahmi specifically developed by the internationally renowned Central Drug Research Institute (CDRI), in India. Brahmi is a creeping plant that is found in damp marshy regions and is extensively used in both India and Japan. Of all Indian herbs, Brahmi has been throughout history the premier herb for memory. Although practitioners and their patients have known of Brahmi for thousands of years it was the Central Drug Research Institute (CDRI), through formal scientific studies, that determined a precise extraction process and helped understand exactly how it works.
How does it work?
The CDRI discovered that Brahmi contained two main active molecules. The molecules are Bacosides A & B. They have, in extensive clinical research and trials over the past 50 years, demonstrated a strong improvement in helping ease mild age related memory loss and concentration difficulties. * CDRI researchers have found that Bacosides A &B supported this by increasing protein kinase activity and significantly enhancing new protein synthesis, particularly in brain cells in the regions of the brain connected with memory. *
SomaLife Memory also contains Phosphatidylserine and Phosphatidylcholine, two compounds, known as phospholipids that are essential components in all cells and cell membranes and are vital to brain structure and function. * These phospholipids are abundant in the brain, and are intricately involved in relaying chemical messages between the cells. * When supplemented orally, both are rapidly absorbed where they have positive effects on brain cell structure and metabolism, enhancing the function of neuronal membranes, and cerebra cell metabolism. *
Also contained in SomaLife Memory is a standardized Gingko Biloba extract, which has been used by Chinese herbalists for at least 5000 years. At a cellular level Ginkgo’s antioxidant effects are attributed mainly to the flavanoids present in the extract. * It has been scientifically formulated to work synergistically with the other three ingredients. Gingko Biloba has been shown to increase blood flow to the brain. *
The unique formulation of an ancient herbal formulae and modern ingredients make SomaLife Memory one of the most talked about dietary supplements available in the world. * The SomaLife Scientific Team continues its search of ancient natural formulae’s that have been used for hundreds and sometimes thousands of years and which can be clinically proven and validated. By bringing formulas from countries such as India, China, Russia or other ancient cultures and combining them with natural, safe, modern ingredients we continue our commitment to bring our distributors the finest and safest natural products from the four corners of the world. These products blended together in proprietary formulae clearly establish us as the most innovative nutraceutical company in the world.
* This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
|
|
|
|
|
|
